Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/03/050878
CTRI/2023/03/050878
Recruiting
N/A

A prospective interventional study to assess role of an integrated approach of Homoeopathy along with WHO Rehabilitation self-management care for long COVID: Single blind placebo controlled randomized trial

Central Council for Research in Homoeopathy0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: U071- COVID 19 virus identified

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: U071- COVID 19 virus identified
Sponsor
Central Council for Research in Homoeopathy
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Central Council for Research in Homoeopathy

Eligibility Criteria

Inclusion Criteria

  • •History of confirmed COVID\-19 infection in last 6 months; Minimum 4 weeks after the confirmed COVID\-19 report.
  • •Residual or any other clinical complaints reported to be occurring after COVID\-19 like fatigue, fever (unknown reason), anxiety, joint pain, breathlessness, headache, or any other non\-serious clinical illness not explained by an alternative diagnosis.
  • •Cases who have recovered clinically\&/or laboratory confirmed negative.
  • •Patients agreeing to perform WHO self\-care rehabilitation program under guidance of the physician.
  • •Patients willing to participate in the study and give written informed consent

Exclusion Criteria

  • •Patients having any serious sequelae, presence of systemic complications (persistent organic damage) or specific organ dysfunction due to SARS\-CoV\-2 virus.
  • •Uncontrolled cases of DM, HT, Asthma, HIV, active TB, Cancer, immune compromised illness like HIV etc.
  • •Patients having severe dyspnoea with Oxygen saturation below 95%; patients requiring ventilation support
  • •Patient reporting having Psychiatric disorders, hepatic and renal dysfunction.
  • •Contra indications to physical exercise or Patient unable to do exercise in the WHO rehabilitation self\-management care plan.
  • •Patients not able to give written informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
Phase 2
Argentum Nitricum in cases of irritate bowel syndromeHealth Condition 1: K58- Irritable bowel syndrome
CTRI/2023/09/057286I
Not Yet Recruiting
Phase 3
To observe the effect of extension of epidural space with normal saline on the effect of spinal anaesthesia using low dose of local anaesthetic i.e., high density BUPIVACAINE in patients undergoing infraumbilical surgeriesHealth Condition 1: I839- Asymptomatic varicose veins of lower extremitiesHealth Condition 2: S720- Fracture of head and neck of femurHealth Condition 3: R103- Pain localized to other parts of lower abdomen
CTRI/2023/04/051776ESIC Medical College and Hospital
Recruiting
N/A
A study to find the effectivity of single injection of the drug Razumab in improving vision in the affected eye .This study will help the patients with diabetic eye problems by improving their vision and reducing the number of hospital visits.Health Condition 1: H00-H59- Diseases of the eye and adnexa
CTRI/2022/05/042804ESIC postgraduate institute of medical science and research
Completed
N/A
Can yoga reduce the need of medication after surgery?Health Condition 1: null- Cholelithiasis
CTRI/2018/01/011355self funded452
Not Yet Recruiting
N/A
A study to assess the role of CognitiveBotics software (Artificial Intelligence based software) in the management of Autism Spectrum Disorder.Health Condition 1: F840- Autistic disorder
CTRI/2023/06/054257CognitiveBotics Technologies Private Limited